Literature DB >> 18241684

2. Dendritic cells as regulators of immunity and tolerance.

Natalija Novak1, Thomas Bieber.   

Abstract

Dendritic cells (DCs) are antigen sampling sentinels of the peripheral tissue and specialists for antigen capture, processing, and presentation to T cells as well as T-cell priming. By virtue of their mission as antigen samplers, they populate the body surfaces that line the border of our organism with the environment such as the skin and the mucosa of the respiratory and the gastrointestinal tract. Although all DCs share some classic features, their individual organ-specific phenotype and function are ascertained by a complex, dynamic network of co-regulatory factors provided by their microenvironment. DC subtypes might initiate novel inflammatory immune responses as well as accelerate or break down ongoing inflammatory immune reactions in the skin, the gut, and the respiratory tract. On the basis of the recognition of self-signals or nonself-signals in the presence or absence of danger signals, the interplay of DC antigen uptake and presentation leads into immunosilencing or immunoactivating properties, which designate the outcome of tolerance or defensive immunity within the skin, the gut, or the respiratory tree.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241684     DOI: 10.1016/j.jaci.2007.06.001

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  17 in total

1.  Radiation and immunotherapy: a synergistic combination.

Authors:  Anusha Kalbasi; Carl H June; Naomi Haas; Neha Vapiwala
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

Review 2.  Pathogenesis of indirect (secondary) acute lung injury.

Authors:  Mario Perl; Joanne Lomas-Neira; Fabienne Venet; Chun-Shiang Chung; Alfred Ayala
Journal:  Expert Rev Respir Med       Date:  2011-02       Impact factor: 3.772

3.  Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism.

Authors:  Ayman Elsheikh; Sidonie N Lavergne; J Luis Castrejon; John Farrell; Haiyi Wang; Jean Sathish; Werner J Pichler; B Kevin Park; Dean J Naisbitt
Journal:  J Immunol       Date:  2010-10-27       Impact factor: 5.422

4.  Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.

Authors:  Hongmei Li; Patricia Gonnella; Farinaz Safavi; Ghazal Vessal; Bardia Nourbakhsh; Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Neuroimmunol       Date:  2012-09-23       Impact factor: 3.478

Review 5.  3G11 expression in CD4+ T cell-mediated autoimmunity and immune tolerance.

Authors:  Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Int Immunopharmacol       Date:  2010-11-24       Impact factor: 4.932

Review 6.  Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.

Authors:  Charles B Smarr; Paul J Bryce; Stephen D Miller
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

7.  Blockage of thymic stromal lymphopoietin signaling improves acute lung injury in mice by regulating pulmonary dendritic cells.

Authors:  Guoquan Pan; Yafeng Liang; Lu Lu; Xu Chen; Min Wang; Linxia Wang; Chunxue Yan; Weixi Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 8.  Renal dendritic cells: an update.

Authors:  Peter Velázquez; Michael L Dustin; Peter J Nelson
Journal:  Nephron Exp Nephrol       Date:  2009-03-10

9.  Immune responses elicited by apoB-100-derived peptides in mice.

Authors:  Chrysoulla Pierides; Alexandra Bermudez-Fajardo; Gunilla Nordin Fredrikson; Jan Nilsson; Ernesto Oviedo-Orta
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

10.  CD11c+CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis.

Authors:  Hongmei Li; Guang-Xian Zhang; Youhai Chen; Hui Xu; Denise C Fitzgerald; Zhao Zhao; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.